Your browser doesn't support javascript.
loading
Exploratory study of ultraviolet B (UVB) radiation and age of onset of bipolar disorder.
Bauer, Michael; Glenn, Tasha; Achtyes, Eric D; Alda, Martin; Agaoglu, Esen; Altinbas, Kürsat; Andreassen, Ole A; Angelopoulos, Elias; Ardau, Raffaella; Aydin, Memduha; Ayhan, Yavuz; Baethge, Christopher; Bauer, Rita; Baune, Bernhard T; Balaban, Ceylan; Becerra-Palars, Claudia; Behere, Aniruddh P; Behere, Prakash B; Belete, Habte; Belete, Tilahun; Belizario, Gabriel Okawa; Bellivier, Frank; Belmaker, Robert H; Benedetti, Francesco; Berk, Michael; Bersudsky, Yuly; Bicakci, Sule; Birabwa-Oketcho, Harriet; Bjella, Thomas D; Brady, Conan; Cabrera, Jorge; Cappucciati, Marco; Castro, Angela Marianne Paredes; Chen, Wei-Ling; Cheung, Eric Y W; Chiesa, Silvia; Crowe, Marie; Cuomo, Alessandro; Dallaspezia, Sara; Del Zompo, Maria; Desai, Pratikkumar; Dodd, Seetal; Etain, Bruno; Fagiolini, Andrea; Fellendorf, Frederike T; Ferensztajn-Rochowiak, Ewa; Fiedorowicz, Jess G; Fountoulakis, Kostas N; Frye, Mark A; Geoffroy, Pierre A.
Afiliação
  • Bauer M; Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany. michael.bauer@uniklinikum-dresden.de.
  • Glenn T; ChronoRecord Association, Fullerton, CA, USA.
  • Achtyes ED; Division of Psychiatry and Behavioral Medicine, Michigan State University College of Human Medicine, Grand Rapids, MI, USA.
  • Alda M; Pine Rest Christian Mental Health Services, Grand Rapids, MI, USA.
  • Agaoglu E; Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
  • Altinbas K; Department of Psychiatry, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Andreassen OA; Department of Psychiatry, Selcuk University Faculty of Medicine, Mazhar Osman Mood Center, Konya, Turkey.
  • Angelopoulos E; NORMENT Centre, Division of Mental Health and Addiction, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Ardau R; Department of Psychiatry, National and Capodistrian University of Athens, Medical School, Eginition Hospital, Athens, Greece.
  • Aydin M; Section of Neurosciences and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Sardinia, Italy.
  • Ayhan Y; Department of Psychiatry, Selcuk University Faculty of Medicine, Konya, Turkey.
  • Baethge C; Department of Psychiatry, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Bauer R; Department of Psychiatry and Psychotherapy, University of Cologne Medical School, Cologne, Germany.
  • Baune BT; Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus, Faculty of Medicine, Technische Universität Dresden, Dresden, Germany.
  • Balaban C; Department of Psychiatry, University of Münster, Münster, Germany.
  • Becerra-Palars C; Department of Psychiatry, Melbourne Medical School, The University of Melbourne, Melbourne, Australia.
  • Behere AP; The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, VIC, Australia.
  • Behere PB; Department of Psychiatry, Psychosomatic Medicine and Psychotherapy, University Hospital Frankfurt, Johann Wolfgang Goethe-Universität Frankfurt Am Main, Frankfurt Am Main, Germany.
  • Belete H; National Institute of Psychiatry "Ramón de la Fuente Muñiz", Mexico City, Mexico.
  • Belete T; Department of Pediatrics and Human Development, Michigan State University, Grand Rapids, MI, USA.
  • Belizario GO; Department of Psychiatry, Jawaharlal Nehru Medical College, Datta Meghe Institute of Medical Sciences (Deemed University), Wardha, India.
  • Bellivier F; Department of Psychiatry, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
  • Belmaker RH; Department of Psychiatry, College of Medicine and Health Sciences, Bahir Dar University, Bahir Dar, Ethiopia.
  • Benedetti F; Bipolar Disorder Research Program, Department of Psychiatry, University of São Paulo Medical School, São Paulo, Brazil.
  • Berk M; Département de Psychiatrie et de Médecine Addictologique, Assistance Publique, Hôpitaux de Paris, INSERM UMR-S1144, Université Paris Cité, Fondation FondaMental, Paris, France.
  • Bersudsky Y; Division of Psychiatry, Ben Gurion University of the Negev, Beer Sheva, Israel.
  • Bicakci S; University Vita-Salute San Raffaele, Milan, Italy.
  • Birabwa-Oketcho H; Psychiatry and Clinical Psychobiology, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
  • Bjella TD; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Australia.
  • Brady C; Orygen The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, Florey Institute for Neuroscience and Mental Health and the, Department of Psychiatry, The University of Melbourne, Melbourne, Australia.
  • Cabrera J; Department of Psychiatry, Faculty of Health Sciences, Beer Sheva Mental Health Center, Ben Gurion University of the Negev, Beer Sheva, Israel.
  • Cappucciati M; Department of Psychiatry, Hacettepe University Faculty of Medicine, Ankara, Turkey.
  • Castro AMP; Department of Psychiatry, Baskent University Faculty of Medicine, Ankara, Turkey.
  • Chen WL; Butabika Hospital, Kampala, Uganda.
  • Cheung EYW; NORMENT Centre, Division of Mental Health and Addiction, Oslo University Hospital and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Chiesa S; Department of Psychiatry, Trinity College Dublin, St Patrick's University Hospital, Dublin, Ireland.
  • Crowe M; Mood Disorders Clinic, Dr. Jose Horwitz Psychiatric Institute, Santiago de Chile, Chile.
  • Cuomo A; Department of Mental Health and Substance Abuse, Piacenza, Italy.
  • Dallaspezia S; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Australia.
  • Del Zompo M; Department of Psychiatry, Chiayi Branch, Taichung Veterans General Hospital, Chiayi, Taiwan.
  • Desai P; Private Practice, Central, Hong Kong, China.
  • Dodd S; Department of Mental Health and Substance Abuse, Piacenza, Italy.
  • Etain B; Department of Psychological Medicine, University of Otago, Christchurch, New Zealand.
  • Fagiolini A; Department of Molecular Medicine, University of Siena School of Medicine, Siena, Italy.
  • Fellendorf FT; Psychiatry and Clinical Psychobiology, Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.
  • Ferensztajn-Rochowiak E; Section of Neurosciences and Clinical Pharmacology, Department of Biomedical Sciences, University of Cagliari, Sardinia, Italy.
  • Fiedorowicz JG; Division of Psychiatry and Behavioral Medicine, Michigan State University College of Human Medicine, Grand Rapids, MI, USA.
  • Fountoulakis KN; Pine Rest Christian Mental Health Services, Grand Rapids, MI, USA.
  • Frye MA; IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Australia.
  • Geoffroy PA; Department of Psychiatry, University of Melbourne, Parkville, VIC, Australia.
Int J Bipolar Disord ; 11(1): 22, 2023 Jun 22.
Article em En | MEDLINE | ID: mdl-37347392
BACKGROUND: Sunlight contains ultraviolet B (UVB) radiation that triggers the production of vitamin D by skin. Vitamin D has widespread effects on brain function in both developing and adult brains. However, many people live at latitudes (about > 40 N or S) that do not receive enough UVB in winter to produce vitamin D. This exploratory study investigated the association between the age of onset of bipolar I disorder and the threshold for UVB sufficient for vitamin D production in a large global sample. METHODS: Data for 6972 patients with bipolar I disorder were obtained at 75 collection sites in 41 countries in both hemispheres. The best model to assess the relation between the threshold for UVB sufficient for vitamin D production and age of onset included 1 or more months below the threshold, family history of mood disorders, and birth cohort. All coefficients estimated at P ≤ 0.001. RESULTS: The 6972 patients had an onset in 582 locations in 70 countries, with a mean age of onset of 25.6 years. Of the onset locations, 34.0% had at least 1 month below the threshold for UVB sufficient for vitamin D production. The age of onset at locations with 1 or more months of less than or equal to the threshold for UVB was 1.66 years younger. CONCLUSION: UVB and vitamin D may have an important influence on the development of bipolar disorder. Study limitations included a lack of data on patient vitamin D levels, lifestyles, or supplement use. More study of the impacts of UVB and vitamin D in bipolar disorder is needed to evaluate this supposition.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Int J Bipolar Disord Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Int J Bipolar Disord Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha